79 results
Page 3 of 4
8-K
EX-1.1
7vs0mkye
5 Jun 19
Sientra Commences Public Offering of Common Stock
4:10pm
424B5
ckmk695qgz1b nm
5 Jun 19
Prospectus supplement for primary offering
4:03pm
424B5
6cje8vxud66g73
3 Jun 19
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
5icuy7cum 92r
21 Mar 19
Sientra® Issues Statement in Response to FDA Post-Approval Study Warning Letter
4:40pm
8-K
5tpb5 n7ne258b
21 Mar 19
Sientra® Issues Statement in Response to FDA Post-Approval Study Warning Letter
4:40pm
424B5
jmmpduu5f3x308o0ro
4 May 18
Prospectus supplement for primary offering
6:13am
8-K
EX-1.1
9xp8v kha9pl70
4 May 18
Sientra Commences Public Offering of Common Stock
6:07am
424B5
i3zq3l
30 Apr 18
Prospectus supplement for primary offering
7:05am